Optiver Holding’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Optiver Holding's REGN Position: Q3 2026 in Review
Optiver Holding opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 1 share worth $758. The stake represents ﹤0.01% of the portfolio and ranks #1652 among its holdings. This is a return to the name: Optiver Holding previously reported a position in REGN as recently as Q4 2025.
Optiver Holding first reported a position in REGN in Q2 2021 and has held it in 8 quarters since. The position peaked at $206K in Q1 2024. 1,432 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Optiver Holding held 1 share of Regeneron Pharmaceuticals worth $758 as of Q3 2026.
- Regeneron Pharmaceuticals was a new Optiver Holding position in Q3 2026.
- Regeneron Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q3 2026, its #1652 holding.
- Optiver Holding first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 8 quarters since.
- Optiver Holding's Regeneron Pharmaceuticals position peaked at $206K in Q1 2024.
- 1,432 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Optiver Holding's 13F filing for Q3 2026, filed 16 Nov 2026.